BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals, Inc., a leading innovator in oral bioavailability solutions, announced today that it will present case studies based on the company’s Quadrant 2™ solubilization platform at three conferences in June. Quadrant 2 is the first formulation technology to follow quality by design (QbD) guidelines and to combine materials science and molecular modeling to deliver optimized formulations for poorly soluble drugs.
BUCHI Advanced Hands-on Spray Drying Course
When: 6/4/14 - 6/5/14
Where: Newark, DE
Information and registration: www.mybuchi.com/index.php?id=33801
2014 Land of Lakes R&D Conference:
Particle Engineering in API and Drug Product Design
When: 6/9/14 - 6/12/14
Where: Madison, WI
Information and registration: http://ce.pharmacy.wisc.edu/mod/coursepage/view.php?id=3961
Catalent Applied Drug Delivery Institute: Innovation Showcase –
Advanced Drug Delivery Approaches for Small and Large Molecules
Where: St. Paul, MN
Information and registration: www.drugdeliveryinstitute.com/events/
For more information, please contact Agere at firstname.lastname@example.org.
Agere is a leading CDMO focused on improving the oral bioavailability of insoluble active pharmaceutical ingredients (APIs). The company supports clients from screening to identify the optimal solubilization technology, through formulation design and development into cGMP manufacturing for Phase I through Phase IIb clinical trials. All services follow QbD guidelines and are delivered on a fee-for-service basis. Agere’s proprietary formulation design platform, Quadrant 2™, enables the company to deliver a customized solution for every compound to serve each individual client’s requirements. The company is located in Bend, OR. For information: www.agerepharma.com.
Agere Pharmaceuticals and Quadrant 2 are trademarks owned by Agere Pharmaceuticals, Inc.